BTSR yields 200000000.00% · PFE yields 6.13%● Live data
📍 BTSR pulled ahead of the other in Year 1
Combined, BTSR + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BTSR + PFE for your $10,000?
BrightStar Information Technology Group, Inc. provides application engineering services to Global 2000 and midsized companies, and public sector organizations in the United States. It helps organizations in implementing and /or supporting enterprise-level packaged-systems applications and legacy software systems. The company primarily operates in two areas, Enterprise Resource Planning and Legacy Systems. In the Enterprise Resource Planning area, BrightStar implements and /or supports software from SAP, A.G., covering a range of business processes, including finance, human resources, and payroll. It also provides training and other consulting services related to Actuate software, which retrieves business information from corporate databases and delivers it as interactive Web pages and Excel spreadsheets. In the Legacy Systems area, it operates as a subcontractor and supports the fiscal intermediary standard system, which is used to process claims under Medicare Part A. In addition, BrightStar provides e-communication solutions and content management systems to clients in the not-for-profit sector, as well as software support and training services to various corporations. The company was founded in 1997 and is based in Pleasanton, California. BrightStar Information Technology Group, Inc. is a subsidiary of Stellar McKim LLC.
Full BTSR Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.